Benzinga | Jul 30, 2021 06:37AM EDT

IDEXX Laboratories Q2 EPS $2.34 Beats $2.04 Estimate, Sales $826.00M Beat $782.99M Estimate; Raises Guidance

IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $2.34 per share which beat the analyst consensus estimate of $2.04 by 14.71 percent. This is a 36.05 percent increase over earnings of $1.72 per share from the same period last year. The company reported quarterly sales of $826.00 million which beat the analyst consensus estimate of $782.99 million by 5.49 percent. This is a 29.55 percent increase over sales of $637.59 million the same period last year.